180 Life Sciences ROCE
Qual é o ROCE de 180 Life Sciences?
O ROCE de 180 Life Sciences Corp. é 14,186.55%
Qual é a definição de ROCE?
O retorno sobre o capital empregado (ROCE) é um índice financeiro que mede a lucratividade de uma empresa e a eficiência com que seu capital é usado.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de empresas na Setor Health Care em NASDAQ em comparação com 180 Life Sciences
O que 180 Life Sciences faz?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas com roce semelhantes a 180 Life Sciences
- Blue Apron Inc tem ROCE de 5,016.13%
- ParkerVision tem ROCE de 5,589.92%
- Asensus Surgical Inc tem ROCE de 5,861.92%
- Whiting USA Trust II tem ROCE de 7,251.43%
- Astra tem ROCE de 7,618.05%
- Kalo Gold tem ROCE de 8,333.61%
- 180 Life Sciences tem ROCE de 14,186.55%
- Ideanomics Inc tem ROCE de 29,881.71%
- Internet Gold - Golden Lines tem ROCE de 31,538.46%
- Predictiv Ai Inc tem ROCE de 33,476.12%
- T2 Biosystems Inc tem ROCE de 56,826.92%
- AMBG tem ROCE de 145,496.28%
- Woluwe Shopping Center tem ROCE de 520,618,500.00%